DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading portal core
324 articles
Boston Children’s Hospital is turning generative AI from a showcase pilot into a clinical tool with measurable impact: more than 40 rare diagnoses and less operational friction around care.
H1 has raised $40 million for a platform that helps healthcare organizations identify and connect with the right providers.
Radio waves are no longer just a background technology for communication: in a new study, they are used as a tool to control spin chemistry in proteins.
Miniature brain-and-spinal-cord systems grown in the lab suggest that what is often treated as irreversible nerve damage may still have a biological switch.
In Asia-Pacific lung cancer screening, AI is no longer a futuristic add-on but a practical attempt to catch tumors that escape old risk lists.
A new analysis suggests Alzheimer’s pathology can be detected in midlife brains before dementia and before a dramatic loss of daily function.
A new brain imaging method targets one of Alzheimer's most important biological traces before symptoms appear, making it clinically important because the treatment window begins before visible cognitive decline.
A new AI-powered spatial atlas does not just ask whether a tumor carries an immune signature, but where that signature sits, how mature it is and what it may say about the course of disease.
Cambridge scientists have grown a lab model of the brain-spinal cord connection and used it to show that damage long treated as irreversible may not always be a one-way injury.
A dental implant is not just a passive screw in bone once peri-implantitis develops: a new report suggests titanium particles may be part of the reason antibiotics often fail.
A molecule long treated mainly as metabolic damage now enters a more precise frame: a possible regulator of early development.
A new UC Davis study shows how AI can improve a meal’s nutrition and cost without radically changing what people already eat.
Menstrual pain is measured here not by a survey, but by the checkout trail left when menstrual products and pain relief appear on the same receipt.
Eosinophils are no longer just an allergy footnote: a new review places them among the cells that could help read how tumors respond to immunotherapy.
New molecular clocks do not just estimate how old tissue is; they try to read lifespan itself from patterns of gene activity.
Headway, a popular virtual therapy platform, is preparing to require facial scans from patients and providers, according to 404 Media, turning privacy into a condition for continued care.
A new Vanderbilt Health-led study warns that dementia may not look the same on brain scans across communities, with direct consequences for diagnosis and treatment access.
ReDLat2 puts dementia in a space where genetics, the exposome and biological clocks have to be read together, not as three separate notes in a medical file.
New research places the protein GPNMB at the center of how Parkinson’s disease may spread through the brain, and where that process might be interrupted.
A new therapeutic idea for depression starts not with serotonin or dopamine, but with the possibility that inflammatory immune signaling may keep symptoms locked in place for some patients.
The Singapore microrobot is not just aiming for a smaller incision, but for a different logic of surgical instrumentation: one device, five functions and tool switching in under one second.
Colon cancer screening is no longer framed only around colonoscopy and stool tests: ACS now brings newer FDA-approved molecular options, including blood tests, into its guidance.
Verge Labs has shifted its center of gravity from AI-powered drug hunting to a more practical neuroscience question: how to identify, earlier, which patients a brain drug is most likely to help.
Dry age-related macular degeneration still lacks a simple early off-ramp, but a new Aalto University idea tries exactly that: warm tissue gently enough for cells to activate their own repair machinery.
The issue is not only that health systems want patient data, but that the right to refuse can become an interface maze designed to stop patients from using it.
SIGnature targets one of single-cell biology’s harder problems: extracting comparable gene-importance scores from large RNA foundation models across datasets.
Guava juice is not an anemia cure, but a new review suggests it could be a cheap nutritional amplifier for iron therapy where low blood levels remain a public-health burden.
Pain in neurofibromatosis type 1 may not begin with a tumor on the nerve, but earlier, in disrupted signaling between Schwann cells and sensory nerves.
Japanese scientists have opened a sharper route toward brain regeneration: chemically enhanced vitamin K compounds that push neural stem cells toward neurons more strongly in the lab.
The Texas A&M nasal spray sounds like a major medical story, but for now it should be read as a promising preclinical signal, not a ready dementia treatment.
When a scientific paper cites a source that does not exist, the problem is no longer just academic sloppiness but a break in the trust chain that can reach clinical decision-making.
AI can accelerate parts of therapeutic antibody design, but BigHat Biosciences’ interview makes clear it is not a magic passage through the costliest and riskiest stages of drug development.
The latest Nature Biotechnology item is not a new experiment but an author correction, yet it touches a paper aimed at one of CRISPR biology’s sharper frontiers: directing Cas12a systems toward RNA targets.
Vagus nerve stimulation is no longer only a story about implants and autonomic control: researchers are now trying to place it more precisely inside movement rehabilitation.
The problem with pulse oximeters is not one number on a screen, but the way that number can decide who gets attention, follow-up testing and faster care.
Eli Lilly says a high dose of Verve’s gene-editing therapy lowered cholesterol by 62% in an early clinical trial.
The FDA has expanded treatment options for one of the hardest newly diagnosed AML groups: older and clinically frailer adults for whom intensive induction chemotherapy is not a realistic route.
Researchers at McGill University have shown how natural killer cells can be temporarily redirected into a stronger attack on tumors that usually survive immune pressure.
Duke researchers are targeting nerve pain where the damaged nerve appears energetically broken: inside its mitochondria.
Topical ABT-263 accelerated wound closure in aged mice and boosted gene signals tied to collagen production and tissue regeneration.
Type 1 diabetes may not begin as a sudden immune attack, but as a slow beta-cell failure in which viral stress and genetic context reshape the cells’ defenses.
Researchers have used light to push chemistry uphill: the creation of tiny, strained housane molecules.
New research shifts part of the Alzheimer’s conversation from simply clearing amyloid to IDOL, an enzyme that may regulate plaques, APOE and neuronal communication.
Topical ABT-263 accelerated wound closure in aged mice and boosted gene signals tied to collagen production and tissue regeneration.
A new analysis of nearly 2,800 breast cancer genomes identifies eight previously undescribed copy-number DNA patterns tied to tumor development and clinical outcomes.
The Geneva experiment does not end insulin tomorrow, but it shows how a bioartificial pancreas could survive in the body long enough to become a serious therapeutic platform.
A new mouse study suggests Alzheimer’s pathology may not have to be attacked only inside neurons, but also through repair of the brain’s cleanup system.
CAR T therapy, one of modern oncology’s most aggressive tools, is now being tested in autoimmune disease, where the target is no longer a tumor but an immune system attacking its own body.
An AI avatar doctor used before a real oncology appointment could become a practical tool for lowering stress and closing understanding gaps for cancer patients.
MYC, long known for driving tumor growth, may also move directly into damaged DNA and help cancer cells repair the very injuries caused by therapy.
New research in Nature Neuroscience pushes mitochondria from the background of neurodegeneration into the foreground: failure in the brain’s energy machinery may not merely follow disease, but help trigger cognitive decline early.
A new meta-analysis presented at the European Congress on Obesity in Istanbul puts a sharper number on a question already reshaping cardiometabolic medicine: how much drug-assisted weight loss lowers blood pressure.
In a new analysis, mpox does not behave like an outbreak that can be tracked only through rash, lesions, and patients who know they are sick.
In a new analysis, mpox does not behave like an outbreak that can be tracked only through rash, lesions, and patients who know they are sick.
Houston Methodist has used a personalized mRNA vaccine in a patient with osteosarcoma in an attempt to reduce relapse risk under FDA compassionate use.
Houston Methodist has used a personalized mRNA vaccine in a patient with osteosarcoma in an attempt to reduce relapse risk under FDA compassionate use.
New research suggests a daily GLP-1 pill could help maintain results achieved with semaglutide or tirzepatide.
Preclinical work at McMaster University suggests a new drug candidate can eliminate glioblastoma tumors in models that usually resist standard treatment.
Researchers at the University of California, Irvine described a wireless, battery-free sensor that continuously tracks multiple sweat biomarkers for 21 days.
Northwestern engineers and clinicians have built a wearable polygraph that tracks five body signals in real time to expose hidden stress, not deception.
Varda Space Industries has signed a deal with United Therapeutics that could turn microgravity into a real production line for drugs.
At SickKids, researchers identified a brain signal that appears before children lose attention and showed that a brief targeted intervention can restore focus.
A wrongful-death lawsuit alleges ChatGPT gave dangerous guidance about a drug combination and failed to escalate the risk.
Research published in JAMA Network Open links psilocybin plus psychotherapy with more cocaine-free days in people with cocaine use disorder.
Research published in JAMA Network Open links psilocybin plus psychotherapy with more cocaine-free days in people with cocaine use disorder.
Vapi reached a $500 million valuation after a $50 million Series B and a win over 40 rivals for Amazon Ring.
A new mouse study suggests that restoring an animal's own youthful gut microbiome can slow biological liver aging and reduce early cancer-linked risk signals.
A new analysis suggests that early type 2 diabetes is not only an insulin story, but also a story of disrupted glucagon signaling and liver metabolism.
A new mouse study strengthens the idea that sperm carries not just DNA, but RNA signals linked to a father’s preconception experiences.
Transferring a gene tied to protective hyaluronic acid production from naked mole rats into mice produced a modest but scientifically important result: the animals lived longer and showed fewer signs of biological decline.
Researchers using a chronic-itch mouse model found that TRPV4 in sensory neurons helps terminate scratching, pointing to a more precise therapeutic question than simply trying to block itch itself.
A uterine-lining organoid lets researchers watch tissue shed and repair without forming scars.
Researchers linked a set of SP genes to regeneration in axolotls, zebrafish and mice, opening an early path to understanding tissue repair.
Rocket Lab is moving from commercial launch cadence into strategic defense through Raytheon’s Golden Dome work and Anduril’s hypersonic test flights.
Mexican researchers are looking for new antimicrobial compounds in scorpion venom and habanero peppers, but the clinical story is only beginning.
Researchers linked a set of SP genes to regeneration in axolotls, zebrafish and mice, opening an early path to understanding tissue repair.
Swedish researchers developed a more reliable way to make insulin-producing cells that restored glucose control in mice.
University of Illinois researchers demonstrated an MRI framework that measures more than 20 brain biomarkers in one scan.
The Johns Hopkins approach lowers the intensity of bone-marrow transplant conditioning, a crucial difference for patients who may not tolerate the standard path.
OpenAI is rolling out GPT-5.5 Instant as ChatGPT's default model with a reported 52.5 percent drop in fabricated claims.
Automated evaluation can scale safety checks, but it must not pretend to be diagnosis.
A breast cancer study mapped 78 paired tumors and metastases, showing how metabolically reprogrammed cells suppress immune response in lymph nodes.
Pretargeted alpha therapy shows striking results in tumor models, but the clinical message must stay precise: this is not yet proof of a human therapy.
An OpenAI model beat doctors in a diagnosis test, but medicine is not a leaderboard.
A new tumor-on-a-chip model does not promise a cure for pancreatic cancer, but it sharpens the view of why the tumor’s tissue environment protects it so stubbornly.
Ten4 guides neuron migration by switching between adhesion and repulsion in the developing brain.
A new preclinical study changes an old assumption: for mRNA vaccines, the key is not only which antigen is delivered, but where the body expresses it.
ARTEMIS reached more than 70,000 adolescents in New Delhi and Vijayawada and enrolled 3,739 young people for care evaluation.
A new preclinical study changes an old assumption: for mRNA vaccines, the key is not only which antigen is delivered, but where the body expresses it.
Sixian You's team published their counterintuitive finding in Nature Methods on April 28.
UC Santa Cruz researchers trained brain organoids using electronic signals, boosting their success rate from 4.5% to 46%.
MSK researchers link two genomic signals to resistance against CDK4/6 inhibitors in metastatic breast cancer.
Researchers published findings on April 17 detailing how ML models analyze atopic dermatitis to forecast respiratory illness.
WEHI’s Nature paper reveals ubiquitin tags can bind glycogen, upending 70 years of metabolic dogma.
SS Innovations’ SSi Vimana Aero drone pairs a robotic arm with autonomous flight, targeting 60-second deployments in contested zones.
The discovery focused on excitatory neurons and microglia, revealing disrupted circuits in donated brain tissue from 26 donors with depression.
A startup claims it created functional human sperm from stem cells and used it to form embryos, but the evidence has not yet been independently published.
Forty-two β-thalassaemia patients in a Milan-led trial stopped needing blood transfusions after CRISPR edited their *BCL11A* gene to boost fetal hemoglobin.
A study in *EMBO Molecular Medicine* links MDGA1 gene mutations to autism’s male bias, marking a step toward biological clarity—but no treatment yet.
The Establishing Focus study tracked 1,108 primary care visits to test AI screening for depression using routine dialogue.
Electrodes in epilepsy patients revealed identical brain activity for seeing and imagining objects.
Anglia Ruskin University led the research, which involved collaboration with Cranfield University, the University of Portsmouth, and Intelligent Omics Ltd.
*Crop* replaces *Stardew Valley*’s golden sunrises with Lovecraftian nightmares—and your farm’s failure isn’t just bad luck, it’s *design*.
Conductive polymer traces embedded in a 3D-printed origami structure enable motion at voltages as low as 1kV—no external power tethers required.
A 2024 analysis found 63% of digital mental health platforms now offer AI chatbots—up from 12% in 2020, yet none can cite peer-reviewed superiority over rivals.
A study in *EMBO Molecular Medicine* links MDGA1 gene mutations to autism’s male bias, marking a step toward biological clarity—but no treatment yet.
A study in *GEN News* identifies tunneling nanotubes as a key pathway for mutant huntingtin protein transfer in brain cells.
SymptomWise’s authors didn’t just build an AI diagnostic tool—they designed it to fail gracefully, a rarity in a field where overconfidence is the default setting.
Enteric glial cells—not immune cells—may hold the key to why 30% of IBD patients develop chronic motility disorders post-recovery.
Researchers at Worcester Polytechnic Institute have developed a flexible optical fiber that can be used to destroy hard-to-reach tumors on the vocal folds.
UC San Francisco’s single-cell atlas of pregnancy reveals new cell types linked to preeclampsia, but remains purely research-stage.
SMU’s coil array steers microrobots in dark, camera-free zones—but the demo hides key hardware limits.
MD Anderson’s team pinpointed immune signatures in Lynch Syndrome patients’ blood—yet the study’s lack of sample details leaves clinicians skeptical.
IB101’s defined binding pocket marks a structural advance, but the compound has yet to enter preclinical testing.
ARPA-H’s $100 million joint-repair initiative funds three unnamed teams—only Duke confirmed—to test unproven regenerative therapies in human trials.
Flinders University’s *SLEEP* study exposes a blind spot in sleep medicine: patients with erratic night-to-night apnea patterns face 30% higher cardiovascular risk than severity scores alone predict.
Mouse studies at the German Research Center for Environmental Health reveal astrocytes—once dismissed as neuronal scaffolding—directly activate the brain’s fullness neurons via a glucose-triggered relay.
The article 'Minimal life by computer' presents a significant step forward in the development of virtual cells, with a focus on uniting AI's pattern-finding power with mechanistic models.
Microplastics have been found in every human bile sample examined in a recent study, with chronic low-dose exposure linked to mitochondrial dysfunction and senescence in cholangiocytes.
A multidisciplinary research team has identified a faster way to determine which airborne chemicals pose a threat to human lungs.
Mouse studies now show tumors disable dendritic cells by crippling their mitochondria—a vulnerability that may explain immunotherapy resistance in 30–40% of patients.
A University of Minnesota study shows fecal microbiota transplantation can reverse life-threatening inflammation in fulminant *C. difficile* within hours, slashing mortality risks.
Researchers have developed a blood test that analyzes cell-free DNA to detect multiple cancers, liver conditions, and organ abnormalities.
UCLA scientists have developed a simple and cost-effective blood test that shows promise in detecting multiple cancers, various liver conditions, and organ abnormalities simultaneously.
The ASH HematOmics Program has been developed by a team of scientists from St. Jude Children's Research Hospital, the American Society for Hematology, and the Munich Leukemia Laboratory.
The Mayo Clinic’s new protein-ranking system assigns immunogenicity scores to individual proteins, a capability absent from current transplant risk assessments.
The Salton Sea's environment affects children's lung function growth, with significant implications for public health policy.
Apple’s Studio Display XDR is now the first consumer monitor FDA-cleared for primary diagnostic imaging—a validation previously reserved for $10,000+ medical-grade screens.
Automated evaluation can scale safety checks, but it must not pretend to be diagnosis.
The largest randomized trial of its kind found a computational method for assessing coronary blockages matched invasive testing in 92% of cases—yet regulators and clinicians aren’t ready to call it a replacement.
Spanish researchers found that people with naturally elevated dermcidin levels reported 38% fewer flu-like symptoms during peak season.
Researchers have developed an AI-powered pathology tool that can predict treatment responses for patients with extensive-stage small cell lung cancer, with a reported accuracy rate of over 80%.
A 50-patient randomized trial found no reduction in heart attack size when using Impella CP pumps in high-risk STEMI patients without cardiogenic shock.
A new text-mining method could cut bioprocess trial-and-error—but only if it survives real-world validation.
CANECPI-5, a sugarcane protein, is the key ingredient in this artificial saliva, which has shown promising results in early tests.
Disrupted sleep in depressed young adults predicted insulin resistance more accurately than weight gain in a 10-year Australian study of 1,900 participants.
A single investor just turned $1 million into $385 million—without a drug, a trial, or even a double-digit headcount.
Researchers used CRISPR and epigenetic targeting to reactivate silenced tumor suppressors in AML mouse models, reducing leukemia burden.
The mutations don’t just predict epilepsy—they rewire the brain’s blueprint during the second trimester, according to Baylor’s *Neuron* paper.
Cambridge chemists turned a botched reaction into a method that uses LED light to edit drug molecules—no toxic solvents required.
Dutch surgeons just turned a 3 a.m. liver transplant into a 9 a.m. one—without harming patient outcomes.
Current antifungals fail in 40% of systemic candidiasis cases, a mortality rate driving researchers toward radical alternatives like immune metabolic reprogramming.
The Salton Sea's environment affects children's lung function growth, with significant implications for public health policy.
APOE4 carriers—roughly 1 in 4 people globally—may experience altered brain activity in their 30s, decades before Alzheimer’s symptoms emerge.
Brain scans from 34 countries reveal that air pollution and socioeconomic inequality can widen the gap between biological and chronological brain age by up to two years.
Researchers analyzing 34 countries’ exposome data pinpointed two distinct drivers of brain aging: social interactions speed cognitive decline, while pollutants erode structural integrity.
Ten patients with congenital deafness experienced improved hearing after a single injection of a new gene therapy.
GATC Health claims its AI-driven in silico multi-omics technique reduces therapeutic development costs.
Researchers have identified a small molecule that can prevent kidney stone formation in a rare genetic disorder.
Professor Jason Trubiano’s team just confirmed what clinicians suspected: **90% of hospital patients labeled ‘penicillin-allergic’ test negative** when properly evaluated.
Four types of cancer were eliminated in mice using the new drugs.
A *Nature Medicine* correction to a 2026 whole-genome sequencing study in solid cancers offers no explanation for the changes, leaving clinicians to parse its implications alone.
Swedish researchers exploited hemoproteins like hemoglobin to polymerize conductive n-PBDF directly in brain tissue, sidestepping traditional fabrication barriers.
CRISPR-based tools reactivated a silenced leukemia-suppressing gene in mice, according to JAX researchers, without editing a single DNA base pair.
A preprint study shows new sensors recording neural activity in brain organoids for under $500 per unit, but clinical relevance is years away.
Researchers documented zero major complications in pediatric patients undergoing SEEG-guided thermocoagulation—a rare bright spot in drug-resistant epilepsy treatment.
Epia Neuro’s neural implant doesn’t just assist stroke-damaged hands—it attempts to reprogram the brain’s motor cortex while a robotic glove forces the limb through lost movements.
STAT News analysis reveals the FDA’s ‘breakthrough’ AI devices lean toward broad-impact solutions over niche tools.
The April 2026 *Nature Medicine* editorial doesn’t just call health information important—it classifies unequal access as a *structural determinant of health*, a category previously reserved for factors like income or pollution.
Keratinocytes in the epidermis don’t just detect threats—they broadcast them via a newly identified pathway, Chinese researchers revealed in *Nature Immunology* this week.
Nearly a dozen personalized cancer vaccine platforms are now in human trials, but none have cleared regulatory approval.
Scientists at 404 Media have made a significant discovery, producing psilocybin and DMT in a tobacco plant, with potential implications for medicine and conservation.
Mayo Clinic’s five-year study reveals robotic bronchoscopy’s sub-millimeter accuracy—but clinical adoption lags behind polished demos.
Jean-Jacques Lebrun, Ph.D., led the team that made the breakthrough discovery of a protein that pancreatic cancer cells rely on to survive and grow.
UC Davis researchers’ new blood test targets a protein signature unique to *active* TB—a feature missing from every WHO-approved diagnostic currently in use.
A new text-mining method could cut bioprocess trial-and-error—but only if it survives real-world validation.
Hong Kong researchers engineered a titanium surface that obliterates *Staphylococcus aureus* biofilms in 15 minutes—using light instead of drugs.
A Phase 3 cancer vaccine trial’s undisclosed ‘narrow failure’ last August erased IO Biotech’s $127M IPO and forced a Tuesday SEC bankruptcy filing.
Antiretroviral therapy now extends near-normal lifespans in wealthy nations, yet 60% of new HIV infections still occur in sub-Saharan Africa.
ERAST’s vector database compresses 1 billion biological sequences into a searchable format—yet its paper omits the critical benchmark: how often speed comes at accuracy’s expense.
STAT News reports that a quiet effort to rename PCOS is nearing completion, with growing evidence of a male version of the condition.
A drug originally designed for erectile dysfunction now shows **unexpected muscle-strengthening effects** in children with a fatal neurological disorder.
DNA robots use genetic material to move and carry cargo at nanoscale precision.
Cross-dataset EEG emotion recognition just got a prototype-driven upgrade—on paper, at least, with PAA-L’s local alignment outpacing global adversarial methods in early arXiv tests.
A single compromised repository at CareCloud now forces 45,000+ providers to confront the same question: what patient data might be in the wrong hands?
Over 80% of variants detected in tumor sequencing fall into a gray zone—neither clearly harmful nor benign—where Hiroshima University’s new tool aims to impose order.
The study titled 'Scalable single-cell total RNA sequencing unifies coding and noncoding transcriptomics' was published in Nature Biotechnology on 31 March 2026.
Researchers are exploring a new technology that involves turning muscles into motors to treat spinal cord injuries and Crohn's disease.
Scientists at the Icahn School of Medicine at Mount Sinai have made a significant discovery about the biological processes that contribute to the development of Down syndrome.
Pericardial fat—long a suspected culprit in heart disease—now has an AI-powered measurement tool that outperforms traditional risk models by up to 20%.
A 16-week trial across 13 countries just gave pediatric cardiologists their first phase 3 data on mavacamten for obstructive HCM in youth.
T cells—immune system’s off-meta pick—just outplayed antibodies in a *Cell Reports* study, targeting viral ‘core files’ instead of mutable cosmetics.
Microsoft and Amazon’s new AI health tools process patient data at scale—but neither has cleared FDA validation for clinical use.
Twenty thousand lab-grown human retinas—each a cluster of cells no wider than a sesame seed—just rewrote a key chapter in how cone photoreceptors resist degeneration.
The arXiv paper’s authors admit what KG vendors won’t: 90% of the world’s textual data is still *unstructured noise*—and no one’s cracked the cost-efficient way to turn it into actionable graphs.
A University of Hawaiʻi study uses AI to rank recovery factors, but the real test is whether clinicians—and patients—will trust the results.
Rare mutations in *CHD8* and *SCN2A*—genes long tied to autism in European populations—now appear equally significant in Latin American cohorts, per a 10,000-person study.
Nature Medicine published a study on making infectious disease data local and accessible, with a DOI of 10.1038/s41591-026-04328-3.
Rare mutations in *CHD8* and *SCN2A*—genes long tied to autism in European populations—now appear equally significant in Latin American cohorts, per a 10,000-person study.
A 12-patient trial saw zero relapses and low severe GVHD rates with VIC-1911, but the lack of a control group leaves key questions unanswered.
A team led by neuroscientists at the University of Pennsylvania has compiled the most detailed map yet of brain connectivity across nine decades of life.
A 2023 *Nature Aging* study analyzing sleep EEGs from 10,000+ adults found subtle brainwave patterns that correlated with accelerated biological aging and future dementia risk.
A study of 523 stroke survivors reveals the brain’s undamaged side may temporarily ‘de-age’ to compensate for injury—but the implications for recovery remain unclear.
Dr. James White, MD, found a clear benefit to using the 4D model to target treatment for CRT patients.
Hummingbirds consume alcohol levels equivalent to several human drinks daily—yet show zero signs of impairment.
The FDA’s involvement marks Whoop’s first serious attempt to shift from luxury fitness tracker to medical device.
Over 50% of women with disabilities prefer self-collected HPV tests, per a Journal of Medical Screening study.
CVS faces a settlement over manipulated insulin prices, potentially saving Americans $7 billion.
Gotistobart increased survival in PRESERVE-003 for metastatic squamous NSCLC patients resistant to immunochemotherapy.
AstraZeneca's in vivo CAR-T therapy has shown early responses in 50% of patients, according to Endpoints News.
A 1,700-patient study at the 2024 ESMO Congress found ctDNA detected relapse in triple-negative breast cancer with 85% accuracy.
The hunt for Parkinson’s disease mechanisms just got a new lead: a cellular ‘overflow valve’ that, when broken, may let toxins accumulate.
A British clinical trial participant has controlled *World of Warcraft* for 100 days using only his thoughts—but the data is still just one patient deep.
Optogenetic mapping in 24 mice revealed a neural feedback loop between the amygdala and prefrontal cortex that adjusts fear responses in real time.
The hippocampus and entorhinal cortex—Alzheimer’s favorite targets—now have genetic aging blueprints, thanks to deep learning crunching GWAS data.
Students in Beijing are renting AI glasses for exam cheating, while startups cash in on $6 daily fees with zero hardware upgrades.
New prototype analyzes thousands of molecules simultaneously.
New research in *Genetic Engineering & Biotechnology News* reveals how epigenetic alterations from gut inflammation endure long after healing, potentially setting the stage for colon cancer.
Telmisartan, an FDA-approved blood pressure drug, has been found to enhance the cancer-killing activity of olaparib, according to a study led by Tyler J. Curiel, MD, MPH, FACP.
When parasitic worms invade the gut, the body’s response goes beyond local inflammation.
Vitamin B3 neutralizes microRNA-93, a genetic driver of fatty liver disease.
Current heart failure diagnostics rely on invasive catheters or radiation—yet a Oxford-led team just mapped cardiac oxygen use in three minutes using standard MRI machines.
Denali's Surnazyme treats Hunter syndrome in under 2,000 global patients.
Xaira's X-Cell model is the largest virtual cell model to-date, with 1 million parameters, according to the company's press release.
IB101’s defined binding pocket marks a structural advance, but the compound has yet to enter preclinical testing.
Researchers from UIC have made a significant breakthrough in the treatment of drug-resistant herpes, using an FDA-approved cancer drug, doxorubicin, to target the virus.
Neuroscientists have now measured dopamine’s influence on brain activity in intervals as brief as 100 milliseconds—faster than a human blink.
New blueprint aims to accelerate approvals for rare pediatric gene therapies.
In vivo CAR-T trials show promise, skipping lab processing.
Hummingbirds consume alcohol levels equivalent to several human drinks daily—yet show zero signs of impairment.
A Nature Metabolism study reveals metformin activates the AMPK pathway via the PEN2 protein.
Scientists identify 95% fatality rate for small cell lung cancer patients.
MSKCC's in vivo CAR-T trial shows promise for 5 myeloma patients.
A recent study suggests the brain’s overreaction to minor disturbances may contribute to falls in older adults and Parkinson’s patients.
Tirzepatide + hormone therapy yields 35% more weight loss for women over 50.
CVS faces a settlement over manipulated insulin prices, potentially saving Americans $7 billion.
Kyungpook National University’s MLPH peptide skipped the lab bench’s guesswork—its amino acid sequence was optimized by algorithms before a single test tube was touched.
The 'falls after stroke trial' study found a 33% reduction in falls among stroke survivors over 12 months, according to the British Medical Journal.
Researchers at MIT modified lipid nanoparticles with aromatic compounds.
South Korean materials scientists designed the powder’s particles to resonate at 300 Hz—matching the average electric toothbrush’s vibration frequency—according to the *Journal of Dental Research*.
Researchers documented zero major complications in pediatric patients undergoing SEEG-guided thermocoagulation—a rare bright spot in drug-resistant epilepsy treatment.
IB101’s defined binding pocket marks a structural advance, but the compound has yet to enter preclinical testing.
BIIB094’s phase 1 trial marks the first time an antisense oligonucleotide has successfully targeted LRRK2 in Parkinson’s patients.
The LungIMPACT trial involved over 15,000 participants and found no significant reduction in time to diagnosis with AI-based prioritization.
Researchers have developed stitches that release anti-inflammatory drugs for weeks, but the technology is years from clinical use.
For the 537 million adults living with diabetes worldwide, the ritual of daily insulin injections is a reminder of medicine’s stubborn limits.
The ethical and scientific quagmire of animal testing may have a new contender: genetically engineered, brainless organ systems.
Scientists at Columbia's Zuckerman Institute and the University of Texas at Dallas conducted a study to shed light on how the human brain ages.
Alzheimer’s ‘death switch’ in mice slows plaque buildup—but human trials remain years away.
Australia's Centre for Cancer Biology exposed CD47 as glioblastoma's growth engine, not just an immune shield, yet clinical translation stays distant.
A Swedish study reveals an approved drug can revive immune cells exhausted by HIV—but only in lab dishes, not patients.
For decades, the dream of scarless wound healing has hovered just beyond reach—until now.
Keratinocytes in the epidermis don’t just detect threats—they broadcast them via a newly identified pathway, Chinese researchers revealed in *Nature Immunology* this week.
mRNA cancer vaccines show promise but face years of trials—progress isn’t the same as proven therapy.
New blood test detects 90% of early-stage pancreatic cancer cases with four-marker panel.
Deactivating a brainstem region tied to coughing/laughing in rodents normalized blood pressure—hinting at hypertension’s overlooked neural switch.
Apogee's eczema drug matches Dupixent's relief with fewer injections.
Novartis drops $3B on SNV4818, a PI3Kα inhibitor claiming pan-mutant coverage—where alpelisib’s toxicity and modest efficacy leave room for a rival.
Childhood trauma scars the brain—but 150+ minutes of weekly exercise may rewire its stress circuits, study finds.
Neuroscientists identify synchronized neuron clusters—engrams—as the likely physical basis of memory, but evidence remains observational and limited to anima...
Roche’s breast cancer pill persevERA flunks crucial Phase 3 trial, costing the pharma giant its blockbuster hopes worth billions.
mRNA cancer vaccines show promise but face years of trials—progress isn’t the same as proven therapy.
Texas A&M researchers found FGFR1 boosts cholesterol uptake in prostate cancer cells, fueling tumor growth and therapy resistance.
Blood test for NfL protein predicts post-cardiac-arrest cognitive decline with 84% accuracy in ESC 2026 study.
AI debunks decades of neuroscience dogma: London cabbies’ legendary nav skills don’t come from distinctive brain anatomy.
*E. coli* Nissle, a gut-friendly probiotic, now doubles as a tumor-infiltrating drug manufacturer in lab mice.
153 studies spanning 20 years link early screen time to doubled mental health risks in teens.
A study in *GEN News* identifies tunneling nanotubes as a key pathway for mutant huntingtin protein transfer in brain cells.
Rare patients who continue to suppress HIV after treatment offer an important clue, but they do not yet offer a new care standard.
A single amino-acid change in an experimental T cell receptor improved prostate tumor killing in mouse models.
Researchers have developed TLPath, a machine learning system that infers telomere length from standard H&E-stained histopathology slides — a key indicator of cellular aging and health risks.
A recent study published in Nature Medicine has found that a deep learning model using smartwatch data can predict peak oxygen uptake and unplanned healthcare events in patients with heart failure.
Boston University team finds dopamine signal in mice that encodes movement direction—rewriting how we link vision to action.
A new study links nitric oxide to mTOR overactivation in a subset of autism cases.
A *Nature Biotechnology* review published this March outlines the first coherent vision for AI that could unify genomics, protein folding, and synthetic biology under one model.
Great Ormond Street surgeons achieved what prior attempts could not: a graft that grows with its host.
A new study suggests metastatic cells can push healthy lung cells to produce lipids that support tumor growth.
Human biomarker study flags overactive brain circuits as a schizophrenia drug target—but clinical use remains a decade away.
AI-designed antibody fragments, small enough to be produced inside human cells, have shown potential to neutralize proteins tied to Alzheimer’s and MND—though only in lab models so far.
A first-in-class antimalarial drug candidate, MK7602, has demonstrated human tolerance in early clinical studies, though its efficacy remains unproven.
Swedish researchers have translated nerve signals into leg movement commands, including toe wiggling, in a first for above-knee amputees.
A Boston surgical team rehearsed a high-risk pediatric procedure on a digital twin of the patient’s heart before making the first incision.
Lab-grown CAR T cells bypass external editing—preclinical success against 3 cancers, a major leap for solid tumors.
East Asian men with a missing Y chromosome in their pancreatic cells face 30% higher diabetes odds—*but only if their genetic risk is otherwise low*, per a *Nature Medicine* analysis of 200,000+ genomes.
Xaira Therapeutics has launched X-Cell, an AI model for virtual cell simulation, accompanied by a 57-page technical paper.
In 2019, Georg Schett at Friedrich-Alexander University Erlangen-Nürnberg achieved durable remission in a systemic lupus erythematosus patient using CAR-T therapy — a result that launched a global research expansion beyond oncology.
Austrian team’s sIgA-purifying resin cuts mucosal therapy costs—if stability hurdles clear in trials.
Google has shut down the experimental 'What People Suggest' tool, which fed health queries with summaries pulled from Reddit and similar forums.
A new study published in Nature Biotechnology has developed a generative modeling framework that enables petascale synthesis of designed DNA, with a DOI of 10.1038/s41587-026-03020-8.
Lecanemab, a key Alzheimer's drug, has been found to activate immune cells through the Fc fragment of the antibody, according to researchers.
The first public user of an invasive brain-computer interface will demonstrate Neuralink's chip to a professional audience, but the real measure of success happens when the cameras go dark.
A breakthrough noninvasive method measures beta cell mass in living patients—potentially rewriting type 1 diabetes treatment strategies.
Researchers published findings on April 17 detailing how ML models analyze atopic dermatitis to forecast respiratory illness.
New method measures cancer’s hidden gene-splicing toolkit, proving tumors weaponize RNA editing to fuel growth and survival.
Lecanemab, a key Alzheimer's drug, has been found to activate immune cells through the Fc fragment of the antibody, according to researchers.
New method measures cancer’s hidden gene-splicing toolkit, proving tumors weaponize RNA editing to fuel growth and survival.
Human blood now carries 420ppm CO₂—higher than ever in history—and doctors don’t know what it does to our health.
A new wearable device designed to measure flatulence has produced an unexpected preliminary finding: humans may pass gas significantly more often than previously believed.
Cambridge chemists turned a botched reaction into a method that uses LED light to edit drug molecules—no toxic solvents required.
A new amino acid formulation appears to improve LNP uptake in cells, though no human data yet exists.
PETRUSHKA is the first mental-health AI to prove itself in a randomized clinical trial: patients were 40 percent less likely to drop their antidepressant regimen within eight weeks.
A new study published in Nature Medicine has provided some of the most comprehensive evidence yet that oral antibiotics can permanently alter the composition of the gut microbiome.
Radial is not another AI tool; it is an attempt to repair the slower layer of science: data, verification, reproducibility, and knowledge transfer.
Science Tokyo has developed boron agents that target ASCT2, a transporter found in aggressive tumors, instead of the standard LAT1 route.
PALPABLE wants to return palpation to minimally invasive surgery: a soft robotic fingertip that reads tissue stiffness while the surgeon works through instruments.
University College London scientists have reconstructed video purely from mouse neural activity, using visual-cortex electrodes and a dynamic deep-learning model—no external camera needed.
A semaglutide-bimagrumab combo in phase 2 preserved nearly all lean mass while cutting fat dramatically.
The discovery of metabolic enzymes directly on human DNA blurs the boundary between cellular energy, gene regulation, and cancer biology.
Ipsen's decision to pull Tazverik affects thousands of patients worldwide.
Gene mutations disrupt cortical layer formation in early brain development.
Stanford’s engineered CAR-astrocytes cut amyloid-beta plaques by 40–60% in Alzheimer’s-prone mice, but only when given before pathology began.
A breast cancer study mapped 78 paired tumors and metastases, showing how metabolically reprogrammed cells suppress immune response in lymph nodes.
A father and daughter with no lifestyle risk factors led Mayo Clinic to uncover a rare genetic cause of fatty liver disease.
A Bronze Age sheep from Russia’s Ural Mountains is the first non-human host ever found carrying the ancient plague bacterium *Yersinia pestis*.
LRG1, a protein previously linked to blood vessel formation, now stands accused of starving retinal cells in diabetic mice by constricting their microvasculature.
A stem-cell therapy for Parkinson’s disease crosses an important regulatory threshold in Japan, but this is not a moment for miracle language.
Two genes, *Tcf7* and *Lef1*, act as master regulators of T cell exhaustion, according to a *Nature Immunology* study combining CRISPR screens with 60,000-cell sequencing.
The AI model, trained on genome-wide DNA fragmentation data, distinguished early fibrosis from healthy controls with 85% accuracy in preliminary tests—no mutations required.
Former ARPA-H data chief Shannon Sartin is pushing a policy to turn patient health data into a regulated utility, potentially upending its current corporate ownership.
Zorevunersen reduced seizures by up to 91 percent in early trials involving children with Dravet syndrome.
Kobe University's system needs only two photos: dorsal hand view and clenched fist.
Obesity treatment may have just taken a measured step forward.
East Asian men with a missing Y chromosome in their pancreatic cells face 30% higher diabetes odds—*but only if their genetic risk is otherwise low*, per a *Nature Medicine* analysis of 200,000+ genomes.
